LionGate

Long Position ADAP - Reaching All time low (BE CAUTIOUS)

看多
LionGate 已更新   
NASDAQ:ADAP   Adaptimmune Therapeutics plc
As the company ADAP has not been performing as desired within the last few years, an analysis may manifest that the trajectory for the stock valuation has almost amassed an all-time low valuation.

Not investment advice. For personal and educational purposes only. (Move with caution and due diligence)
交易結束:目標達成:
Take Profit, as the stock valuation has breached through prior resistance!

- LionGate
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。